SR-9009 (Stenabolic) in Germany: legal status and DmMV exposure in 2026

Legal status in Germany

No marketing authorization. Never entered human clinical trials. Listed in Germany's DmMV with the lowest threshold among research SARMs — 75 mg.

Approval and regulatory body

No EMA, BfArM, or any global authorization. Developed at the Scripps Research Institute as a Rev-ErbA agonist tool compound. Animal studies showed exercise-capacity effects via mitochondrial biogenesis, but no human clinical trials have ever been conducted.

Scheduling

Not listed in BtMG. Explicitly listed in DmMV 2023 under Rev-erbα-Agonisten — 'SR9009, synonym Stenabolic' — with a non-trivial-quantity threshold of 75 mg. This is the lowest threshold among the four research-chemical compounds named in the DmMV.

Doping (WADA) status

WADA prohibited list 2026: listed under S4.4.1 (Metabolic Modulators, Rev-erbα agonists). 'Rev-erbα agonists, e.g. SR9009, SR9011.' Banned in-competition and out-of-competition. Non-Specified Substance. See the official WADA Prohibited List.

Prescription reality

None. No authorized product exists. No prescribing pathway is available anywhere.

Compounding pharmacy nuance

Not realistic — no GMP raw material in legitimate supply chain.

Research-use legal basis

Sales labeled 'for research use only, not for human consumption' fall outside AMG when sellers do not present the product as medicinal. The DmMV listing means possession in quantities above 75 mg without legitimate research purpose creates AntiDopG criminal exposure under §4. A standard research chemical liquid (10 mg/mL × 30 mL = 300 mg) is 4× the threshold.

Import & customs in Germany

Intra-EU shipments do not exempt German residents from AntiDopG/DmMV restrictions or AMG §73 prohibitions.

Non-EU personal import

Prohibited under §73 AMG. The 75 mg threshold is so low that nearly any commercial-format SR-9009 product (typical 30 mL vials at 10 mg/mL) places the recipient in DmMV territory upon receipt. Customs seizure routinely triggers AntiDopG investigation referral.

Research import

Permitted to registered research entities with proper documentation.

Typical seizure outcome

Letter from Zoll requesting research entity status. Without proof, shipment is destroyed. Above 75 mg — i.e., almost any retail bottle — AntiDopG criminal referral risk is substantial.

Market reality on the ground

Pharmacy availability: Zero. No prescription pathway exists.

Telehealth pathway: No legitimate German telehealth provider issues prescriptions — there is no legal pathway.

Domestic research-chem sellers: Available from European and Chinese-sourced research chemical vendors shipping to Germany.

Underground use: Niche presence in German underground endurance sports and metabolic health communities. The combination of zero human clinical data, explicit DmMV listing, and the lowest possession threshold among research SARMs makes SR-9009 among the more legally risky research chemicals in Germany.

Prices are observational ranges as of May 8, 2026, not endorsements. We do not link to research-chemical sellers.

Where DOSED stands on this

SR-9009 sold in Germany carries a "research chemical, not for human consumption" label for a reason. The compound has no marketing authorization, no clinical trials registered, and no Apotheken pathway. The label is not marketing — it is the legal status. We do not provide dosing protocols, route-of-administration guidance, or vendor referrals. We do not make medical claims about safety or efficacy. We catalog the regulatory reality so you can make informed decisions, then point you to a licensed physician for any health decision that involves your body.

The aim here is the same one in every DOSED page: evidence over influence. Whatever you decide is on you. Our job is to make sure the decision is informed.